Quantitative metabolic profiles of 2nd and 3rd trimester human amniotic fluid using 1H HR-MAS spectroscopy
- First Online:
- 459 Downloads
To establish and compare normative metabolite concentrations in 2nd and 3rd trimester human amniotic fluid samples in an effort to reveal metabolic biomarkers of fetal health and development.
Materials and methods
Twenty-one metabolite concentrations were compared between 2nd (15–27 weeks gestation, N = 23) and 3rd (29–39 weeks gestation, N = 27) trimester amniotic fluid samples using 1H high resolution magic angle spinning (HR-MAS) spectroscopy. Data were acquired using the electronic reference to access in vivo concentrations method and quantified using a modified semi-parametric quantum estimation algorithm modified for high-resolution ex vivo data.
Sixteen of 21 metabolite concentrations differed significantly between 2nd and 3rd trimester groups. Betaine (0.00846±0.00206 mmol/kg vs. 0.0133±0.0058 mmol/kg, P < 0.002) and creatinine (0.0124±0.0058 mmol/kg vs. 0.247±0.011 mmol/kg, P < 0.001) concentrations increased significantly, while glucose (5.96±1.66 mmol/kg vs. 2.41±1.69 mmol/kg, P < 0.001), citrate (0.740±0.217 mmol/kg vs. 0.399±0.137 mmol/kg, P < 0.001), pyruvate (0.0659±0.0103 mmol/kg vs. 0.0299±0.286 mmol/kg, P < 0.001), and numerous amino acid (e.g. alanine, glutamate, isoleucine, leucine, lysine, and valine) concentrations decreased significantly with advancing gestation. A stepwise multiple linear regression model applied to 50 samples showed that gestational age can be accurately predicted using combinations of alanine, glucose and creatinine concentrations.
These results provide key normative data for 2nd and 3rd trimester amniotic fluid metabolite concentrations and provide the foundation for future development of magnetic resonance spectroscopy (MRS) biomarkers to evaluate fetal health and development.
KeywordsElectronic reference to access in vivo concentrations (ERETIC) Gestational age High-resolution magic angle spinning (HR-MAS) Spectroscopy High-resolution quantum estimation (HR-QUEST) Human amniotic fluid
- 15.Joe BN, Swanson MG, Zektzer AS, Kurhanewicz J, Qayyum A, Coakley FV, Yeh BM (2005) Non-invasive evaluation of fetal lung maturity by MR spectroscopy: a preliminary ex-vivo investigation. Am J Roentgenol 184(4): 16–17Google Scholar
- 16.Joe BN, Vahidi K, Zektzer A, Chen MH, Clifton MS, Butler T, Keshari K, Kurhanewicz J, Coakley F, Swanson MG (2008) H-1 HR-MAS spectroscopy for quantitative measurement of choline concentration in amniotic fluid as a marker of fetal lung maturity: inter-and intraobserver reproducibility study. J Magn Reson Imaging 28(6): 1540–1545CrossRefPubMedGoogle Scholar
- 24.Holmes E, Foxall PJ, Spraul M, Farrant RD, Nicholson JK, Lindon JC (1997) 750 MHz 1H NMR spectroscopy characterisation of the complex metabolic pattern of urine from patients with inborn errors of metabolism: 2-hydroxyglutaric aciduria and maple syrup urine disease. J Pharm Biomed Anal 15(11): 1647–1659CrossRefPubMedGoogle Scholar
- 25.Uyeno D (1919) The physical properties and chemical composition of human amniotic fluid. J Biol Chem 37(1): 77–103Google Scholar
- 27.Becker ED (2000) High resolution NMR: theory and chemical applications. Academic Press, San DiegoGoogle Scholar
- 31.Rabenstein DL, Keire DA (1991) Quantitative chemical analysis by NMR. In: Popov IA, Halenga K (eds) Modern NMR techniques and their application in chemistry. Marcel Dekker, New York, pp 323–369Google Scholar
- 43.Johnsen SL, Rasmussen S, Sollien R, Kiserud T (2005) Fetal age assessment based on femur length at 10–25 weeks of gestation, and reference ranges for femur length to head circumference ratios. Acta Obstet Gynecol Scan 84(8): 725–733Google Scholar